IDH1 and anaplastic astrocytoma: In fact, we found 77.8% (7/9) of diffuse and 100% (7/7) of anaplastic astrocytomas presenting IDH1 mutation, whereas 92.9% (3/42) of GBMs were wild-type for IDH1 mutation, corroborating this data.